MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today announced positive data demonstrating the accuracy and decision making value of ConfirmMDx and...

Researchers from Invitae (NYSE: NVTA), a leading genetics company, will present a study of more than 6,500 patients with uterine cancer showing that genetic testing provided more than 80 percent...

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), today announced that results from the pivotal rimegepant Zydis® ODT Phase 3 clinical trial will be presented as a late-breaking oral...

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company with a heritage of more than 70 years in eye care, will present new data for its investigational implant, Bimatoprost SR, and a...

BTX Global Logistics gathered its executive team, branch owners and managers for a systems-wide conference focused on strategic planning, training and comradeship from April 7-10. This year's...